{"id":"62b717d6-1573-48ec-8315-cbd417de1f2b","kind":"institutions","code":"UB-I8385","name":"Yingxi Intelligence","nameBasis":"transliterated","summary":"Yingxi Intelligence, an investment entity undertaking strategic investments.","description":"Yingxi Intelligence, an investment entity undertaking strategic investments.","country":null,"category":null,"originalName":"英矽智能","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:26:18.054Z","englishUpdatedAt":"2026-10-15T17:35:39.114Z","reviewedAt":"2026-10-15T17:35:39.114Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"259cd55ef6f013ccfeb4cc36895d0e45ded8d507ef1a446cfac3893fc5e3a7c6","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"英矽智能，开展战略投资的投资主体。","sources":[],"related":[{"id":"4d1e3597-94fd-49fc-a8fd-ab996fe80708","kind":"news","code":"4d1e3597-94fd-49fc-a8fd-ab996fe80708","name":"Yuanmazhiyao raises tens of millions of RMB in Pre-Series A financing","nameBasis":"translated-title","summary":"On 2026-07-22, according to Xiniu Data, Yuanmazhiyao completed Pre-Series A financing, raising tens of millions of RMB. Investors were Yifeng Capital, Yingxi Intelligence and others. The company is a developer of circular mRNA-based in vivo CAR-T therapies.","description":"","country":null,"category":null,"originalName":"元码智药完成Pre-A轮融资，金额数千万人民币","eventDate":"2026-07-22T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:17.433Z","englishUpdatedAt":"2026-10-15T20:49:12.979Z","reviewedAt":"2026-10-15T20:49:12.979Z","snapshotAt":"2026-10-15T18:31:34.288Z","sourceHash":"71b023c5a008b872588e1e5d9f2b2d10116caaf6fded04215132adadf1708952","companyId":"d8b9bfd5-1e23-4188-84ec-0527f602ddbc","foundedYear":null,"logoUrl":null,"path":"/news/4d1e3597-94fd-49fc-a8fd-ab996fe80708"}],"path":"/institutions/yingxi-intelligence","canonical":"https://uniquebase.ai/institutions/yingxi-intelligence"}